We intend to maintain the standards established by ACE and adhere to identified best practices. Our patients deserve nothing less. - Robert J. Rogalski, chief executive officer of Excela Health
Washington, DC (PRWEB) March 18, 2015
A continued commitment to excellence is sweeping through cardiac catheterization laboratories. The cardiac catheterization laboratory and angioplasty/stenting program at Excela Health, in Greensburg, Pennsylvania has just been reaccredited by ACE.
"ACE standards are even more rigorous than when we initially certified,” said Howard P. Grill, MD, FACC, medical director of Excela Health’s cardiac catheterization laboratory. “We have continued to modify our practices and adapt to these stringent guidelines to ensure we meet the quality measures ACE sets forth. We are honored that the result of our efforts meets their criteria for providing the safest, highest quality, evidence-based care possible.”
Excela Health has been a standard-bearer for cardiovascular excellence since 2012, when it became the first health system in Pennsylvania to achieve initial ACE accreditation, and is now the first cardiac catheterization laboratory in the state to be reaccredited.
“This rigorous review and outstanding recognition of our cardiac catheterization services reflects to all those we serve our deep commitment to practicing medicine with quality and integrity in an environment that puts patients first,” said Robert J. Rogalski, chief executive officer of Excela Health. “We intend to maintain the standards established by ACE and adhere to identified best practices. Our patients deserve nothing less.”
Two other ACE-accredited facilities have also been recognized for their commitment to cardiovascular quality. Baylor Scott & White Hospital in Temple, Texas, and Emory University Hospital Midtown in Atlanta, Georgia, have been named among the nation’s 50 Top Cardiovascular Hospitals by Truven Health Analytics.
According to Truven Health, the 50 Top Cardiovascular Hospitals deliver better patient outcomes while operating more efficiently than other high-volume hospitals. Compared with other facilities, the 50 Top Cardiovascular Hospitals demonstrate higher inhospital survival rates for myocardial infarction (MI) and heart failure (HF), lower complication rates, lower readmission rates for MI and HF, shorter lengths of stay, and lower costs per patient case.
The 2015 50 Top Cardiovascular Hospitals study shows that if all facilities in the U.S. performed at the level of quality of Baylor Scott & White, Emory, and the other 2015 Top 50 winners:
- Nearly 9,500 additional patient lives could be saved
- Nearly 3,000 fewer bypass and angioplasty patients would experience complications
- More than $1.1 billion in costs could be saved
Is your cardiac catheterization program ready to show a similar commitment to quality? Facilities seeking ACE accreditation and reaccreditation can obtain more information and complete the application process at http://www.cvexcel.org.
About Accreditation for Cardiovascular Excellence (ACE)
ACE is the global leader in accreditation and external quality review services for all catheter-based cardiovascular procedures. ACE, an independent organization sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology Foundation (ACCF), offers independent evaluation and monitoring of facilities that provide cardiovascular care. By reviewing facility and operator performance and comparing clinical decision-making to nationally accepted best practices, ACE quality review and accreditation services play a critical role in continuous quality improvement programs. Join us. Let us exceed your expectations and provide a free consultation. Contact ACE at info(at)cvexcel(dot)org or call our office at 202.657.6859 or visit our website at http://www.cvexcel.org.